聊城治疗羊羔疯病的大概价钱(潍坊哪里看癫痫比较好) (今日更新中)

SAN FRANCISCO, July 12 (Xinhua) -- Google+, the social networking service Google unveiled only two weeks ago, is estimated to surpass 10 million users on Tuesday, possibly becoming the fastest growing product in the history of the Internet.According to Ancestry.com founder Paul Allen (not the co- founder of Microsoft), after passing 10 million users, Google+ " could reach 20 million users by this coming weekend if they keep the Invite Button available."Allen looks for last names on Google+ and compares them with U. S. Census Bureau data on the popularity of surnames to statistically project the number of Google+ users."Since I have been tracking this same cohort of surnames from my first day, I am able to accurately measure growth over time," he said in a blog post on Google+ website.Google so far has not released any details about the Google+ users or the number of users. Speaking at a press event last Thursday in Sun Valley in the U.S. state of Idaho, former Google CEO and current Executive Chairman Eric Schmidt said there are " millions" of users.Industry watchers think the estimate may not be completely accurate, but Allen should be capturing the growth trajectory of Google+, which shows that a social network could undergo an exponential growth in its early days.

LOS ANGELES, June 10 (Xinhua) -- The Aquarius/SAC-D observatory, NASA's first ever satellite to study the saltiness of Earth's oceans, is in excellent health after its launch early Friday, initial telemetry reports showed.The observatory rocketed into space from Vandenberg Air Force Base in California atop a United Launch Alliance Delta II rocket at 7:20:13 a.m. PDT (10:20:13 a.m. EDT).Less than 57 minutes later, the observatory separated from the rocket's second stage and began activation procedures, establishing communications with ground controllers and unfurling its solar arrays, NASA's Jet Propulsion Laboratory (JPL) said.During the next 25 days, the Aquarius/SAC-D service platform will be tested and maneuvered into its final operational, near-polar orbit 408 miles (657 kilometers) above Earth. Science operations will begin after the observatory's instruments are checked out. This commissioning phase may last up to 65 days, JPL said.Aquarius will map the global open ocean once every seven days for at least three years with a resolution of 93 miles (150 kilometers). The maps will show how ocean surface salinity changes each month, season and year. Scientists expect to release preliminary salinity maps later this year."Aquarius is a critical component of our Earth sciences work, and part of the next generation of space-based instruments that will take our knowledge of our home planet to new heights," said NASA Deputy Administrator Lori Garver. "The innovative scientists and engineers who contributed to this mission are part of the talented team that will help America win the future and make a positive impact across the globe."Aquarius will measure salinity by sensing thermal microwave emissions from the water's surface with three microwave instruments called radiometers. When other environmental factors are equal, these emissions indicate the saltiness of surface water. A microwave radar scatterometer instrument will measure ocean waves that affect the precision of the salinity measurement.Because salinity levels in the open ocean vary by only about five parts per thousand, Aquarius will be able to detect changes as small as approximately two parts per 10,000, equivalent to about one-eighth of a teaspoon of salt in a gallon of water."Data from this mission will advance our understanding of the ocean and prediction of the global water cycle," said Michael Freilich, director of NASA's Earth Science Division in the Science Mission Directorate at agency headquarters in Washington. "This mission demonstrates the power of international collaboration and accurate spaceborne measurements for science and societal benefit. This would not be possible without the sustained cooperation of NASA, CONAE and our other partners."The Aquarius/SAC-D (Satellite de Aplicaciones Cientificas) observatory is a collaboration between NASA and Argentina's space agency, Comision Nacional de Actividades Espaciales (CONAE).Aquarius was built by NASA's JPL and the Goddard Space Flight Center in Greenbelt, Maryland. NASA's Launch Services Program at the Kennedy Space Center in Florida manages the launch.JPL will manage Aquarius through its commissioning phase and archive mission data. Goddard will manage Aquarius mission operations and process science data. CONAE is providing the SAC-D spacecraft, optical camera, thermal camera with Canada, microwave radiometer, sensors from various Argentine institutions and the mission operations center. France and Italy also are contributing instruments.

BEIJING, Aug. 26 (Xinhua) -- China's maritime authority on Friday once again urged U.S. oil giant ConocoPhillips to finish cleaning up oil spills in north China's Bohai Bay as soon as possible.Aug. 31 is the deadline set by the government. "There are only five days to go before the arrival of the deadline," said a statement of the State Oceanic Administration (SOA).The SOA urged ConocoPhillips China to adopt all technical measures that could be used to clean up oil spills, and to do it "with an active manner."Liu Cigui, head of the SOA, said Thursday that his administration is collecting evidence and gauging the ecological impact of the spills in preparation for possible legal action against the company.ConocoPhillips China, a subsidiary of ConocoPhillips, first reported the oil spills in June. The spills have spread to beaches in Hebei and Liaoning provinces and been blamed for losses in local tourism and aquatic farming industries.Although the company has worked to clean up the spills, pollutants have still been found in the bay, even after cleanup efforts were reported to be complete.ConocoPhillips China admitted that a total of 16 oil spill sources have been found in the bay as of Friday.

Beijing, Sept. 13 (Xinhuanet) -- A fear of taking antidepressants often results in people's reluctance of going to see the doctor when they are suffering from depression, a study find.The finding was published Monday in the U.S. journal Annals of Family Medicine.The researchers from the University of California investigated 1,054 adults on why they wouldn't tell the doctors about their depression symptoms, as well as any possible mental disorder.Among the participants, 43 percent admitted that they had been reluctant to tell the doctor about their depression symptoms.Their top concern was the possibility of being prescribed an antidepressant -- a worry voiced by 23 percent of the whole study group.Another 16 percent thought dealing with "emotional issues" is not the doctor's job. And a similar percentage worried that the diagnosis of depression may leave a negative record on their medical records.The study would be helpful for looking into the reasons that patients harbor the attitudes that they do, said Dr. Hellerstein of the New York State Psychiatric Institute and Columbia University Medical Center in New York.

BEIJING, Sep. 13 (Xinhuanet) --Experts have called for a national drug-control system after a nationwide deficit of a life-saving drug, which has lasted at least three months.Doctors at a Beijing hospital said some specialized hospitals, which perform hundreds of cardiac operations every month, have been paralyzed by their lack of protamine sulfate, which is commonly administered after heart surgery to reverse the anticoagulant effects of heparin.The earliest report of a shortage was in Hubei province on July 21. This was followed by reports of shortages in Guangdong, Shandong and Liaoning provinces.The Shandong newspaper, Qilu Evening News, quoted a regional sales manager, surnamed Zhuang, as saying the province had been allocated 150 doses of protamine sulfate after Shanghai No 1 Biochemical and Pharmaceutical Co Ltd recently resumed production of the drug."But its monthly use here is usually 10,000 doses," he said.The Ministry of Health has denied it is responsible for supplies of the drug and passed the buck to the State Food and Drug Administration, claiming the latter is responsible for the supervision of medicines.Shen Chen, head of the publicity office of the State Food and Drug Administration, said he was unaware of the shortage, but said the administration is responsible for the quality of medicines, not the supply."Development and reform authorities oversee the medicines' prices, while the industrial and commercial authorities oversee the storage. The food and drug departments only cover the approval and quality of medicines."Industry insiders said one of the reasons for the shortage was the low profit margin, which discourages companies from mass producing the drug."Some companies can't earn enough to recover their costs, therefore it is almost impossible to maintain their enthusiasm for continuing production," said Lu Guoping, secretary-general of the Shanghai Pharmaceutical Trade Association.Lu said the government should issue policies to prevent future shortages of such medicines to avoid possible nationwide public health incidents.Yi Shenghua, a lawyer at Beijing Yingke Law Firm, said the country should have a unified system to guarantee the normal supply of medicines that are widely used and drug manufacturers should fulfill their responsibilities to society, even though there is no law stipulating they should produce specific medicines.He came up with two ways to deal with the problem of companies only producing profitable drugs."The government can order businesses to manufacture a certain amount of cheap medicines. Or it can offer financial assistance to subsidize cheap, but life-saving medicines."

来源：资阳报